Effects of Breathing Training on Psychosocial Functioning and Heart Rate Variability in Postmenopausal Women With Depressive Symptoms-2

September 25, 2014 updated by: Pei-Shan Tsai, National Science Council, Taiwan

The specific aims of this study are:

  1. To develop a breathing training protocol specifically designed to improve HRV and psychosocial functioning for postmenopausal women with depressive symptoms,
  2. To examine the immediate effects of an 8-week breathing training program on HRV and psychosocial end points in postmenopausal women with depressive symptoms,
  3. To examine the intermediate-term effects of an 8-week breathing training program on HRV and psychosocial end points in postmenopausal women with depressive symptoms, and
  4. To determine whether the change in depressive symptoms with breathing training in postmenopausal women is associated with the change in HRV.

Study Overview

Status

Withdrawn

Conditions

Detailed Description

Postmenopausal women without hormone replacement therapy are associated with higher risk of cardiac morbidity and mortality. They are likely to experience depressive symptoms after menopause, and the comorbidity of depression are related to altered autonomic function. We expect that postmenopausal women with depressive symptoms who receive breathing training will demonstrate decreased depressive symptoms and increased heart rate variability immediately upon and later after completion of training, and optimally contributing to improve autonomic nervous regulation in their later life to prevent undesired cardiac outcomes.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Xinyi Dist.
      • Taipei, Xinyi Dist., Taiwan, 110
        • Taipei Medical University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 64 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Permanent termination of menstruation of natural cause.
  • Cessation of menstrual cycles for more than 12 consecutive months.
  • A score of the Chinese version of Beck Depression Inventory-II of greater than 10.
  • Able to speak Mandarin or Taiwanese.
  • Age from 45 to 64 years.

Exclusion Criteria:

  • Subjects who are clinically diagnosed with history of cardiac arrhythmia, coronary heart disease, heart failure, kidney disease, hypertension, chronic low blood pressure, diabetic neuropathy, psychosis, mental deficiency.
  • Subjects who received hormone replacement therapy prescribed by gynecological physicians.
  • Subjects who took cardiac and/or psychotropic medications which may affect the autonomic functions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Breathing training
Respiratory sinus arrhythmia biofeedback-assisted deep breathing training
Respiratory sinus arrhythmia biofeedback-assisted deep breathing training
Active Comparator: Stress management
Cognitive reconstructive strategies for stress management
Cognitive reconstructive strategies for stress management

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Depressive symptoms
Time Frame: baseline
baseline
Depressive symptoms
Time Frame: posttest (8 weeks from baseline)
posttest (8 weeks from baseline)
Depressive symptoms
Time Frame: follow-up (16 weeks from baseline)
follow-up (16 weeks from baseline)

Secondary Outcome Measures

Outcome Measure
Time Frame
Heart rate variability (Resting, reactivity to stress, and recovery from stress)
Time Frame: baseline
baseline
Heart rate variability (Resting, reactivity to stress, and recovery from stress)
Time Frame: posttest (8 weeks from baseline)
posttest (8 weeks from baseline)
Heart rate variability (Resting, reactivity to stress, and recovery from stress)
Time Frame: follow-up (16 weeks from baseline)
follow-up (16 weeks from baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2010

Study Registration Dates

First Submitted

January 7, 2010

First Submitted That Met QC Criteria

January 8, 2010

First Posted (Estimate)

January 11, 2010

Study Record Updates

Last Update Posted (Estimate)

September 26, 2014

Last Update Submitted That Met QC Criteria

September 25, 2014

Last Verified

September 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NSC98-2629-B-038-002-MY3-TMUH

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postmenopause

Clinical Trials on Breathing training

3
Subscribe